CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Baird Adjusts Price Target on Edwards Lifesciences to $94 From $87, Maintains Neutral Rating

Neutral
AI Analysis

Summary

Baird adjusted its price target on Edwards Lifesciences to $94 from $87 while maintaining a Neutral rating.

Importance:2/10
Sentiment:
0.00
price_targetanalyst_rating
Related Companies

Read the original article

Published by yahoo_finance on July 14, 2026 11:45 AM

Read Original